Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (131-140 of 685) with videos related to

Pageof 69
Sort By:
Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.
The Breast Journal|September 9, 2009
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burdenRegina M Fearmonti, Larissa I Batista, Funda Meric-Bernstam, et al.
Journal of Hematology & Oncology|August 3, 2014
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialVivek Subbiah, Funda Meric-Bernstam, Gordon B Mills, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Two birds with one stone: octreotide treatment for acromegaly and breast cancerYoung Kwang Chae, Mimi I Hu, Ruth L Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant AccrualChad Tang, Kenneth R Hess, Dwana Sanders, et al.
Annals of Surgical Oncology|September 21, 2010
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseMin Yi, Sharon Hermes Giordano, Funda Meric-Bernstam, et al.
Cell|January 9, 2018
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell SequencingAnna K Casasent, Aislyn Schalck, Ruli Gao, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Pageof 69

Showing results (131-140 of 685) with videos related to

Sort By:
Pageof 69
Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.
The Breast Journal|September 9, 2009
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burdenRegina M Fearmonti, Larissa I Batista, Funda Meric-Bernstam, et al.
Journal of Hematology & Oncology|August 3, 2014
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialVivek Subbiah, Funda Meric-Bernstam, Gordon B Mills, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Two birds with one stone: octreotide treatment for acromegaly and breast cancerYoung Kwang Chae, Mimi I Hu, Ruth L Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant AccrualChad Tang, Kenneth R Hess, Dwana Sanders, et al.
Annals of Surgical Oncology|September 21, 2010
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseMin Yi, Sharon Hermes Giordano, Funda Meric-Bernstam, et al.
Cell|January 9, 2018
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell SequencingAnna K Casasent, Aislyn Schalck, Ruli Gao, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Pageof 69